# CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/crispr-cas9-engineered-universal-cd19-cd22-dual-targeted-car-t-cell-therapy-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yongxian Hu,Yali Zhou,Mingming Zhang,Wengang Ge,Yi Li,Li Yang,Guoqing Wei,Lu Han,Hao Wang,Shuhui Yu,Yi Chen,Yanbin Wang,Xiaohong He,Xingwang Zhang,Ming Gao,Jingjing Yang,Xiuju Li,Jiangtao Ren,He Huang |
| Citations | 282 |
| DOI | 10.1158/1078-0432.ccr-20-3863 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://aacrjournals.org/clincancerres/article-pdf/27/10/2764/3082923/2764.pdf |
| OpenAlex ID | https://openalex.org/W3132062361 |
| PMID | 33627493 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Yali Zhou](https://scholariq.org/researchers/yali-zhou/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.